Cumberland Pharmaceuticals

• 

  Cumberland Pharmaceuticals Announces New Program To Develop Vasculan™ For Systemic Sclerosis

  2:04 PM | April 27, 2016

  – FDA clears investigational new drug submission – Phase II Clinical Study initiated NASHVILLE, Tenn., April 27, 2016 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for underserved patient populations, announced today the addition of VASCULANTM to its pipeline. Cumberland has initiated the clinical development of VasculanTM (ifetroban) oral capsule for the treatment of systemic sclerosis. The U.S. Food and Drug Administration (FDA) has cleared Cumberland’s investigational new drug application

  Read more

• RMES – Red Metal Resources Drills at Farellon

  1:26 PM | November 5, 2013

  Red Metal Resources (PublicWire.com Press Release) — THUNDER BAY, ON and VALLENAR, Chile, Nov. 5, 2013 /PRNewswire/ – Red Metal Resources Ltd. (OTCQB:RMES), a mineral exploration company with copper-gold assets in Chile, is pleased to announce that its Chilean subsidiary, Minera Polymet Limitada, (“Polymet”) has drilled two holes on its Farellon property. Minera Polymet Ltda. has completed two reverse circulation drill holes totaling 116 metres, targeting an area previously drilled in 2011. The target of the drilling was to expand

  Read more